Is Macquarie Healthcare I (DLHIX) a Strong Mutual Fund Pick Right Now?

Zacks
Ouvrir sur Zacks
Is Macquarie Healthcare I (DLHIX) a Strong Mutual Fund Pick Right Now?

Sector - Health fund seekers may want to consider taking a look at Macquarie Healthcare I (DLHIX). DLHIX bears a Zacks Mutual Fund Rank of 3 (Hold), which is based on various forecasting factors like size, cost, and past performance.

Objective

The world of Sector - Health funds is an area filled with options, such as DLHIX. Healthcare is one of the biggest sectors of the American economy, and Sector - Health mutual funds provide a great opportunity to invest in this industry. Here, funds can include everything from for-profit hospitals to pharmaceutical companies and medical device manufacturers.

History of Fund/Manager

Nomura is responsible for DLHIX, and the company is based out of New York, NY. The Macquarie Healthcare I made its debut in September of 2007 and DLHIX has managed to accumulate roughly $597.41 million in assets, as of the most recently available information. The fund's current manager, Liu Er Chen, has been in charge of the fund since September of 2007.

Performance

Of course, investors look for strong performance in funds. This fund in particular has delivered a 5-year annualized total return of 9.81%, and it sits in the top third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3-year annualized total return of 19.69%, which places it in the top third during this time-frame.

It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.

When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Compared to the category average of 12.23%, the standard deviation of DLHIX over the past three years is 14.06%. Over the past 5 years, the standard deviation of the fund is 14.2% compared to the category average of 13.88%. This makes the fund more volatile than its peers over the past half-decade.

Risk Factors

The fund has a 5-year beta of 0.5, so investors should note that it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. DLHIX has generated a positive alpha over the past five years of 1.86, demonstrating that managers in this portfolio are skilled in picking securities that generate better-than-benchmark returns.

Expenses

Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, DLHIX is a no load fund. It has an expense ratio of 0.96% compared to the category average of 0.97%. DLHIX is actually cheaper than its peers when you consider factors like cost.

Investors need to be aware that with this product, the minimum initial investment is $0; each subsequent investment has no minimum amount.

Fees charged by investment advisors have not been taken into consideration. Returns would be less if those were included.

Bottom Line

Overall, Macquarie Healthcare I ( DLHIX ) has a neutral Zacks Mutual Fund rank, and in conjunction with its comparatively strong performance, average downside risk, and lower fees, this fund looks like a somewhat average choice for investors right now.

This could just be the start of your research on DLHIX in the Sector - Health category. Consider going to www.zacks.com/funds/mutual-funds for additional information about this fund, and all the others that we rank as well for additional information. If you are more of a stock investor, make sure to also check out our Zacks Rank, and our full suite of tools we have available for novice and professional investors alike.

Discover the Stocks Our Experts Want to Own This Quarter

Each quarter, four Zacks editors compile their favorite stocks into one report. As a sign of the times, three of this quarter's picks can potentially cash in on the massive AI boom. One grew its commercial revenue more than 140% last quarter.

The fourth stock is an online retailer posting its most significant growth since the pandemic. Its shares jumped more than 25% after its last earnings report, then pulled back, giving investors a chance to capitalize on what could be a longer-term bullish trend.

Get Your Free Ultimate Four Report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Get Your Free (DLHIX): Fund Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research